Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Sales: 2011-2025

Historic Return on Sales for Abeona Therapeutics (ABEO) over the last 13 years, with Sep 2025 value amounting to -60.44%.

  • Abeona Therapeutics' Return on Sales rose 6329.00% to -60.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -60.44%, marking a year-over-year increase of 6329.00%. This contributed to the annual value of -13.59% for FY2023, which is 2294.00% up from last year.
  • Latest data reveals that Abeona Therapeutics reported Return on Sales of -60.44% as of Q3 2025, which was up 44.63% from -109.16% recorded in Q2 2025.
  • Abeona Therapeutics' Return on Sales' 5-year high stood at 105.00% during Q3 2021, with a 5-year trough of -218.58% in Q1 2025.
  • Its 3-year average for Return on Sales is -65.37%, with a median of -47.46% in 2023.
  • In the last 5 years, Abeona Therapeutics' Return on Sales skyrocketed by 13,446bps in 2023 and then tumbled by 20,734bps in 2025.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' Return on Sales stood at 25.64% in 2021, then slumped by 6,448bps to -38.84% in 2022, then soared by 2,911bps to -9.73% in 2023, then plummeted by 11,277bps to -123.73% in 2024, then soared by 6,329bps to -60.44% in 2025.
  • Its Return on Sales was -60.44% in Q3 2025, compared to -109.16% in Q2 2025 and -218.58% in Q1 2025.